These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 24018024)
1. Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group. Armato SG; Labby ZE; Coolen J; Klabatsa A; Feigen M; Persigehl T; Gill RR Lung Cancer; 2013 Nov; 82(2):190-6. PubMed ID: 24018024 [TBL] [Abstract][Full Text] [Related]
2. Imaging in pleural mesothelioma: A review of the 12th International Conference of the International Mesothelioma Interest Group. Armato SG; Coolen J; Nowak AK; Robinson C; Gill RR; Straus C; Khanwalkar A Lung Cancer; 2015 Nov; 90(2):148-54. PubMed ID: 26298162 [TBL] [Abstract][Full Text] [Related]
3. Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group. Nowak AK; Armato SG; Ceresoli GL; Yildirim H; Francis RJ Lung Cancer; 2010 Oct; 70(1):1-6. PubMed ID: 20541834 [TBL] [Abstract][Full Text] [Related]
4. Morphologic and functional imaging of malignant pleural mesothelioma. Yamamuro M; Gerbaudo VH; Gill RR; Jacobson FL; Sugarbaker DJ; Hatabu H Eur J Radiol; 2007 Dec; 64(3):356-66. PubMed ID: 17954021 [TBL] [Abstract][Full Text] [Related]
6. What is the best way to diagnose and stage malignant pleural mesothelioma? Zahid I; Sharif S; Routledge T; Scarci M Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):254-9. PubMed ID: 21044972 [TBL] [Abstract][Full Text] [Related]
7. Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging. Truong MT; Marom EM; Erasmus JJ J Thorac Imaging; 2006 May; 21(2):146-53. PubMed ID: 16770231 [TBL] [Abstract][Full Text] [Related]
8. Correlation of patient survival with clinical tumor measurements in malignant pleural mesothelioma. Li F; Ahmad M; Qayyum F; Straus CM; MacMahon H; Kindler H; Armato SG Eur Radiol; 2019 Jun; 29(6):2981-2988. PubMed ID: 30617480 [TBL] [Abstract][Full Text] [Related]
9. Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment. Basu S; Saboury B; Torigian DA; Alavi A Mol Imaging Biol; 2011 Oct; 13(5):801-11. PubMed ID: 21136185 [TBL] [Abstract][Full Text] [Related]
10. Current trends in radiologic management of malignant pleural mesothelioma. Gill RR; Gerbaudo VH; Sugarbaker DJ; Hatabu H Semin Thorac Cardiovasc Surg; 2009; 21(2):111-20. PubMed ID: 19822282 [TBL] [Abstract][Full Text] [Related]
11. Early-stage Clinical Characterization of Malignant Pleural Mesothelioma. Negi Y; Kuribayashi K; Funaguchi N; Doi H; Mikami K; Minami T; Takuwa T; Yokoi T; Hasegawa S; Kijima T In Vivo; 2018; 32(5):1169-1174. PubMed ID: 30150440 [TBL] [Abstract][Full Text] [Related]
12. Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group. Armato SG; Francis RJ; Katz SI; Ak G; Opitz I; Gudmundsson E; Blyth KG; Gupta A Lung Cancer; 2019 Apr; 130():108-114. PubMed ID: 30885330 [TBL] [Abstract][Full Text] [Related]
13. Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs. Fodor A; Broggi S; Incerti E; Dell'Oca I; Fiorino C; Samanes Gajate AM; Pasetti M; Cattaneo MG; Passoni P; Gianolli L; Calandrino R; Picchio M; Di Muzio N Clin Lung Cancer; 2019 Jan; 20(1):e29-e38. PubMed ID: 30253920 [TBL] [Abstract][Full Text] [Related]
14. Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma. Nickell LT; Lichtenberger JP; Khorashadi L; Abbott GF; Carter BW Radiographics; 2014 Oct; 34(6):1692-706. PubMed ID: 25310424 [TBL] [Abstract][Full Text] [Related]
15. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma? Sharif S; Zahid I; Routledge T; Scarci M Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493 [TBL] [Abstract][Full Text] [Related]
16. Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group. Armato SG; Blyth KG; Keating JJ; Katz S; Tsim S; Coolen J; Gudmundsson E; Opitz I; Nowak AK Lung Cancer; 2016 Nov; 101():48-58. PubMed ID: 27794408 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in malignant pleural mesothelioma: a retrospective study of 60 Turkish patients. Koyuncu A; Koksal D; Ozmen O; Demirag F; Bayiz H; Aydogdu K; Berkoglu M J Cancer Res Ther; 2015; 11(1):216-22. PubMed ID: 25879365 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesothelioma. Martini K; Meier A; Opitz I; Weder W; Veit-Haibach P; Stahel RA; Frauenfelder T Lung Cancer; 2016 Apr; 94():40-5. PubMed ID: 26973205 [TBL] [Abstract][Full Text] [Related]
19. Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma. Pilling J; Dartnell JA; Lang-Lazdunski L Thorac Cardiovasc Surg; 2010 Jun; 58(4):215-9. PubMed ID: 20514576 [TBL] [Abstract][Full Text] [Related]
20. Imaging in pleural Mesothelioma: A review of the 16th International Conference of the International Mesothelioma Interest Group. Armato SG; Katz SI; Frauenfelder T; Jayasekera G; Catino A; Blyth KG; Theodoro T; Rousset P; Nackaerts K; Opitz I Lung Cancer; 2024 Jul; 193():107832. PubMed ID: 38875938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]